CRISPR Therapeutics (Brazil) Price on January 7, 2025
| C2RS34 Stock | 28.23 1.50 5.05% |
If you're considering investing in CRISPR Stock, it is important to understand the factors that can impact its price. As of today, the current price of CRISPR Therapeutics stands at 28.23, as last reported on the 16th of January 2025, with the highest price reaching 30.48 and the lowest price hitting 27.98 during the day. CRISPR Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0584, which signifies that the company had a -0.0584% return per unit of return volatility over the last 3 months. CRISPR Therapeutics AG exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CRISPR Therapeutics' Coefficient Of Variation of (1,712), risk adjusted performance of (0.04), and Mean Deviation of 1.75 to double-check the risk estimate we provide.
CRISPR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CRISPR |
Sharpe Ratio = -0.0584
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | C2RS34 |
Estimated Market Risk
| 3.29 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CRISPR Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CRISPR Therapeutics by adding CRISPR Therapeutics to a well-diversified portfolio.
CRISPR Therapeutics Valuation on January 7, 2025
It is possible to determine the worth of CRISPR Therapeutics on a given historical date. On January 7, 2025 CRISPR was worth 31.52 at the beginning of the trading date compared to the closed value of 31.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CRISPR Therapeutics stock. Still, in general, we apply an absolute valuation method to find CRISPR Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CRISPR Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CRISPR Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 31.52 | 31.52 | 31.52 | 31.52 | 1.00 | |
01/07/2025 | 31.52 | 31.52 | 31.52 | 31.52 | 1.00 |
| 31.52 | 31.52 | 31.52 | 31.52 | 1.00 |
| Backtest CRISPR Therapeutics | | | CRISPR Therapeutics History | Previous | Next |
CRISPR Therapeutics Trading Date Momentum on January 7, 2025
| On January 08 2025 CRISPR Therapeutics AG was traded for 31.52 at the closing time. The highest price during the trading period was 31.52 and the lowest recorded bid was listed for 31.52 . There was no trading activity during the period 1.0. Lack of trading volume on January 8, 2025 did not affect price variability. The overall trading delta to the current price is 5.68% . |
Price Boundaries
CRISPR Therapeutics Period Price Range
Low | January 16, 2025
| High |
0.00 | 0.00 |
CRISPR Therapeutics AG cannot be verified against its exchange. Please verify the symbol is currently traded on Sao Paulo Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CRISPR Therapeutics January 16, 2025 Market Strength
Market strength indicators help investors to evaluate how CRISPR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CRISPR Therapeutics shares will generate the highest return on investment. By undertsting and applying CRISPR Therapeutics stock market strength indicators, traders can identify CRISPR Therapeutics AG entry and exit signals to maximize returns
CRISPR Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CRISPR Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CRISPR Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CRISPR to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | 0.7671 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CRISPR Stock analysis
When running CRISPR Therapeutics' price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |